2026-04-30T02:24:31Z https://www.peertechzpublications.org/oai-pmh

oai:www.peertechzpublications.org:10.17352/2455-5363.000029 2020-05-20 PTZ.GJIDCR:VOL6

Shock therapy to treat the Novel Coronavirus Disease (COVID-19) by ddNTPs Yeping Tan<p>The Novel Coronavirus (SARS-CoV-2) has caused a massive global outbreak, presenting a significant public health emergency and international concern. Thousands of critically ill patients are dying daily. To date, there are no clinically approved antiviral drug available to cure the Novel Coronavirus infections.&nbsp; I highly recommend the clinical trial of 2’,3’-dideoxyribonucleoside triphosphate (ddNTPs, except ddTTP) to be used for the Novel Coronavirus Disease (COVID-19) antiviral therapy.</p> Global Journal of Infectious Diseases and Clinical Research - Peertechz Publications 2020-05-20 Opinion https://doi.org/10.17352/2455-5363.000029 en Copyright © Yeping Tan et al.